Evidence map›Paper›PMID 34068023›Full record

ReviewJournal of clinical medicine2021

Assessment of the Association of COPD and Asthma with In-Hospital Mortality in Patients with COVID-19. A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.

Felix M Reyes, Manuel Hache-Marliere, Dimitris Karamanis, Cesar G Berto, Rodolfo Estrada, Matthew Langston, George Ntaios, Perminder Gulani, Chirag D Shah, Leonidas Palaiodimos

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Leveraging data-driven insights for esophageal and gastric cancer diagnosis.BMC medical informatics and decision making · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Clinical outcomes among hospitalized US adults with asthma or chronic obstructive pulmonary disease, with or without COVID-19.The Journal of asthma : official journal of the Association for the Care of Asthma · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Felix M ReyesDivision of Pulmonary Medicine, Montefiore Medical Center, Bronx, NY 10461, USA.ORCID 0000-0003-1468-6237
Manuel Hache-MarliereAlbert Einstein College of Medicine, Bronx, NY 10461, USA.
Dimitris KaramanisDepartment of Economics, University of Piraeus, 18534 Attica, Greece.
Cesar G BertoAlbert Einstein College of Medicine, Bronx, NY 10461, USA.
Rodolfo EstradaDivision of Pulmonary Diseases and Critical Care Medicine, University of Texas Health at San Antonio, San Antonio, TX 78229, USA.
Matthew LangstonAlbert Einstein College of Medicine, Bronx, NY 10461, USA.
George NtaiosDepartment of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, 38221 Larissa, Greece.ORCID 0000-0002-0629-9248
Perminder GulaniAlbert Einstein College of Medicine, Bronx, NY 10461, USA.
Chirag D ShahDivision of Pulmonary Medicine, Montefiore Medical Center, Bronx, NY 10461, USA.
Leonidas PalaiodimosAlbert Einstein College of Medicine, Bronx, NY 10461, USA.ORCID 0000-0003-4682-5991
Albert Einstein College of Medicine · USThe University of Texas Health Science Center at San Antonio · USUniversity of Piraeus · GRUniversity of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Together, chronic obstructive pulmonary disease (COPD) and asthma account for the most common non-infectious respiratory pathologies. Conflicting preliminary studies have shown varied effect for COPD and asthma as prognostic factors for mortality in coronavirus disease 2019 (COVID-19). The aim of this study was to explore the association of COPD and asthma with in-hospital mortality in patients with COVID-19 by systematically reviewing and synthesizing with a meta-analysis the available observational studies. MEDLINE, Scopus, and medRxiv databases were reviewed. A random-effects model meta-analysis was used, and I-square was utilized to assess for heterogeneity. In-hospital mortality was defined as the primary endpoint. Sensitivity and meta-regression analyses were performed. Thirty studies with 21,309 patients were included in this meta-analysis (1465 with COPD and 633 with asthma). Hospitalized COVID-19 patients with COPD had higher risk of death compared to those without COPD (OR: 2.29; 95% CI: 1.79-2.93; I

Indexed as

asthmachronic obstructive pulmonary disease (COPD)COVID-19meta-analysismortality

Identifiers

PMID34068023
PMCPMC8152460
OpenAlexW3160903315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.